PharmacoEconomics

, Volume 28, Issue 10, pp 923–930

Comparative Effectiveness, Personalized Medicine and Innovation

The Path Forward
  • Adrian Thomas
  • Audrey Phillips
  • Robert Donnelly
  • Catherine Tak Piech
Industry Perspectives Comparative Effectiveness and Personalized Medicine

DOI: 10.2165/11539030-000000000-0000010.2165/11537370-000000000-00000

Cite this article as:
Thomas, A., Phillips, A., Donnelly, R. et al. Pharmacoeconomics (2010) 28: 923. doi:10.2165/11539030-000000000-0000010.2165/11537370-000000000-00000

Copyright information

© Adis Data Information BV 2010

Authors and Affiliations

  • Adrian Thomas
    • 1
  • Audrey Phillips
    • 2
  • Robert Donnelly
    • 3
  • Catherine Tak Piech
    • 4
  1. 1.Market Access, Johnson & Johnson Pharmaceutical Services LLCRaritanUSA
  2. 2.Biopharmaceutical Public Policy and AdvocacyJohnson & Johnson Government Affairs and PolicyWashington, DCUSA
  3. 3.Health PolicyJohnson & JohnsonWashington, DCUSA
  4. 4.Health Economics and Outcomes ResearchCentocor Ortho Biotech Services LLCTitusvilleUSA
  5. 5.Johnson & JohnsonHorshamUSA